Plasma renin activity as a marker for predicting the antihypertensive effect of switching to sacubitril/valsartan in treated hypertensive patients: Usefulness in daily clinical practice

  • Published on 01/06/2025
  •  Reading time: 3 min.

Takeshi HorioMD, PhD 1, Yoshio IwashimaMD, PhD2,3, Minoru YoshiyamaMD, PhD4, Daiju FukudaMD, PhD5, Tatemitsu RaiMD, PhD3, Kohei FujimotoMD, PhD1

1 Department of Cardiovascular Medicine Ishikiriseiki Hospital Higashiosaka Japan
2 Department of Internal Medicine Kansai Medical University Kori Hospital Neyagawa Japan
3 Department of Nephrology and Hypertension Dokkyo Medical University Mibu Japan
4 Department of Internal Medicine Daito Central Hospital Daito Japan
5 Department of Cardiovascular Medicine Osaka Metropolitan University Graduate School of Medicine Osaka Japan

Abstract

The authors investigated the antihypertensive effect of sacubitril/valsartan (Sac/Val) when switching from other drugs and assessed whether brain natriuretic peptide (BNP) or plasma renin activity (PRA) before drug switching was a predictor of blood pressure lowering after switching to Sac/Val. In 92 patients with treated hypertension, clinic blood pressure, plasma BNP, and PRA were examined before and after switching to Sac/Val. Clinic systolic and diastolic blood pressures...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Cardiology

Receive our newsletter to stay up to date with the latest news in Cardiology